We discount the pain of people we don’t like

According to a new study published in Pain

 

Philadelphia, PA, USA (October 3, 2011) – If a patient is not likeable, will he or she be taken less seriously when exhibiting or complaining about pain? Reporting in the October 2011 issue of Pain®, researchers have found that observers of patients estimate lower pain intensity and are perceptually less sympathetic to the patients‘ pain when the patients are not liked.

 

40 study participants (17 men and 23 women) were preconditioned by viewing pictures of six different patients tagged with simple descriptions that ranged from negative (egoistic, hypocritical, or arrogant) to neutral (true to tradition, reserved, or conventional) to positive (faithful, honest, or friendly). After this preconditioning process, participants observed short videos of the patients undergoing a standardized physiotherapy assessment. The six patients observed were experiencing shoulder pain and eight short video fragments (2 seconds in duration) of each were selected, resulting in 48 different fragments. After each video fragment, the participants were asked to rate the severity of pain of the patients on a scale of "no pain" to "pain as bad as could be." Afterwards, the participants were also asked to judge the patients to be negative or positive, disagreeable or agreeable, and unsympathetic or sympathetic.

 

Investigators found that participants rated patients associated with negative traits as less likeable than patients associated with neutral traits. They rated patients associated with neutral traits as less likable than patients associated with positive traits. Further, pain of disliked patients expressing high intensity pain was estimated as less intense than pain of liked patients expressing high intensity pain. Furthermore, observers were less perceptually sensitive toward pain of negatively evaluated patients than to pain of positively evaluated patients, i.e. they were less able to discriminate between different levels of pain expressed by the disliked patients.

 

"Identifying variables that influence pain estimation by others is relevant as pain estimation might influence crucial actions concerning pain management both in the professional context as well as in the everyday environment," commented lead investigator Liesbet Goubert, PhD, assistant professor of Health Psychology and co-investigator Geert Crombez, PhD, head of the Department of Experimental-Clinical and Health Psychology, Ghent University, Belgium. "Our results suggest that pain of disliked patients who express high pain is taken less seriously by others. This could imply less helping behavior by others as well as poorer health outcomes."

 

 

The article is "When you dislike patients, pain is taken less seriously" by Lies De Ruddere, Liesbet Goubert, Ken Martin Prkachin, Michael André Louis Stevens, Dimitri Marcel Leon Van Ryckeghem, and Geert Crombez (DOI: 10.1016/j.pain.2011.06.028). It appears in Pain®, Volume 152, Issue 10 (October 2011) published by Elsevier.

 

 


Elsevier Health Sciences, 03.10.2011 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…